Medicine and Dentistry
Vinca Alkaloid
100%
Pain
83%
Chemotherapy-Induced Peripheral Neuropathy
83%
Anticarcinogen
66%
Receptor Potential
66%
Ankyrin
66%
Therapeutic Procedure
50%
Diseases
16%
Etiology
16%
Stimulus
16%
Pathogenesis
16%
Cellular Mechanism
16%
Hypersensitivity
16%
Excitation
16%
Afferent Nerve Fiber
16%
Sodium Current
16%
Anaphylaxis
16%
Drug
16%
Chemotherapeutic Agent
16%
Nerve Fiber Degeneration
16%
Nociceptor
16%
Base
16%
Patient
16%
Mutant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vinca Alkaloid
100%
Pain
83%
Chemotherapy-Induced Peripheral Neuropathy
83%
Anticarcinogen
66%
Ankyrin
66%
Mouse
33%
Chemotherapy
33%
Side Effect
33%
Diptera
33%
Diseases
16%
Pathogenesis
16%
Drug Dose
16%
Etiology
16%
Erethism
16%
Drug
16%
Nerve Fiber Degeneration
16%
Anaphylaxis
16%
Base
16%
Animal
16%
Neuroscience
Chemotherapy
100%
Vinca Alkaloid
100%
Neuron
100%
Peripheral Neuropathy
83%
Sensory Neuron
66%
Receptor Potential
66%
Ankyrin
66%
Sodium Current
16%
Nerve Fiber Degeneration
16%
Innervation
16%
Biochemistry, Genetics and Molecular Biology
Sensory Neuron
66%
Receptor Potential
66%
Ankyrin
66%
Mouse
33%
Diptera
33%
Nociceptor
16%
Sodium Current
16%
Drug Dose
16%
Reduction (Chemistry)
16%
Nerve Fiber Degeneration
16%
Animal Models
16%
Mutant
16%
Innervation
16%
Immunology and Microbiology
Receptor Potential
66%
Diptera
33%
Mouse
33%
Anaphylaxis
16%
Hypersensitivity
16%
Drug Dose
16%
Nerve Fiber Degeneration
16%
Immunity
16%
Mutant
16%
Innervation
16%
Reduction (Chemistry)
16%
Sodium Current
16%